GSK said on Friday a panel of the European Medicines Agency had backed the use of its respiratory syncytial virus (RSV) ...
Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...
The recommendation by the CHMP should now result in approval of Arexvy in the broader age range in February next year, and ...
There is underreporting of adverse effects from vaccines; but, in the vast majority of cases, the side effects from the ...
You are correct that there is underreporting of adverse effects from vaccines; however, in the vast majority of cases, the ...
It may feel like you are surrounded by sniffles and coughs, but flu season activity is still low in many parts of the U.S.
You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus ...
The Food and Drug Administration is investigating whether coronavirus vaccines are linked to deaths of adults, part of an ...
The Food and Drug Administration is investigating whether COVID-19 vaccines caused deaths in adults, as part of a safety ...
New CDC report backs COVID vaccine effectiveness in children as vaccine safety probe heats up at FDA
As regulatory uncertainty around COVID vaccines continues to swirl, a new report from the Centers for Disease Control and Prevention (CDC) showcases the benefits of the immunizations among children | ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback